PD(L)-1 inhibitor

DRUG2 trials

Sponsors

Adanate, Inc, Fujian Medical University

Conditions

Solid Tumor, AdultThyroid CancerThyroid Neoplasms

Phase 1

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

TerminatedNCT05601219

Adanate, IncSolid Tumor, Adult

Start: 2022-11-15End: 2024-10-30Updated: 2025-01-28

Unknown Phase

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

RecruitingNCT07419932

Fujian Medical UniversityThyroid Cancer, Thyroid Neoplasms

Start: 2025-12-23End: 2029-06-30Target: 120Updated: 2026-02-19